"Healthy China • Pharmaceutical Subsidy Project" was officially launched. Photo by Wu Tao

  China News Service, Beijing, May 9 (Reporter Wu Tao) In order to effectively reduce the drug burden of the poor, on the 9th, the China Social Poverty Alleviation Network, together with JD Health and JD Public Welfare, launched the "Healthy China • Pharmaceutical Subsidy Project". This project will provide poverty-stricken households (including those who have been lifted out of poverty) with a national registration card, and will provide a subsidy of 1,000 yuan per person per year. The subsidy can be used when purchasing drugs in the specified catalog.

  As of the start, the project's subsidy drug list has more than 350 drugs, covering hundreds of common and chronic diseases including cardio-cerebrovascular, cold and fever, gastrointestinal diseases, and will be rapidly expanded to new special drugs in the future. , Medicines for rare diseases, etc., in order to effectively reduce the burden of medical expenses of poor groups, and help to curb the occurrence of poverty due to illness and the phenomenon of returning to poverty due to illness.

  Data from the National Bureau of Statistics show that, thanks to the National Precision Poverty Alleviation Policy, the incidence of poverty in China has dropped significantly from 10.2% in 2012 to 0.6% at the end of 2019.

  However, there are still many outpatient medicines and regular medicines that are not covered by the medical insurance for the rural poor, and some poor people still face the problems of difficulty and expensive medication.

  Under the guidance of the China Poverty Alleviation and Voluntary Service Association and relying on the China Social Poverty Alleviation Network, the “Healthy China • Pharmaceutical Subsidy Project” will accurately identify the identity information of the poor people across the country and determine the recipients. JD Health will provide the recipients each year With a drug subsidy of 1,000 yuan, the recipient can use it when purchasing the drugs in the subsidy catalogue through the designated channel.

  Since the poor mostly live in remote areas, how to "buy and deliver" medicines becomes the key. While providing drug subsidies, JD Health will use its infrastructure capabilities in the pharmaceutical retail industry to cooperate with JD Logistics to fully leverage the advantages of the supply chain and ensure the supply of drugs in remote areas; In order to improve the supply of drugs in grassroots and remote areas. (Finish)